Table 3

Point prevalence (%) of SL and DP for patients with RA and a matched reference group from the general population, stratified by sex

Days before and after treatment start
−360−270−180−90090180270360
WomenPatients with RA (n=299)SL24.726.131.432.839.832.429.829.130.8
DP31.833.133.835.135.537.537.539.140.5
Reference group (n=1196)SL6.15.85.56.46.46.56.36.06.6
DP9.910.210.610.911.011.411.812.312.6
MenPatients with RA (n=66)SL13.615.219.727.333.325.822.722.724.2
DP27.327.328.828.828.828.828.828.828.8
Reference group (n=264)SL4.23.83.44.53.03.42.72.31.5
DP6.16.16.46.46.46.86.87.68.3
  • DP, disability pension; RA, rheumatoid arthritis; SL, sick leave.